UMF-27254-72288
3 vaccinations
1 coded response
28 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 681 / NE
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
XPH-13832-75195
Child or adolescent in my care · Male · 2022-01-13
Timeline
-
2021-03-06
Registered in v-safe
-
2021-03-06
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-06-10
- 2021-09-04
-
2021-10-22
Dose 2 — Moderna
- 2021-11-02
- 2021-11-07
- 2021-11-12
- 2021-11-21
- 2021-11-27
- 2021-12-03
- 2022-04-22
-
2022-05-07
Dose 3 — ModernaCo-administered: Shingles
- 2022-06-05
- 2022-06-13
- 2022-06-20
-
2022-08-06
Survey response — 3 months, dose 3MedDRA: Cough, Dyspnoea, Nasal congestion, Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Dry cough, sore throat, nasal congestion, shortness of breath, runny nose, feverMedDRA releases: 2024-11 · check-in free text available
-
2022-08-06
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-08
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-07
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-22 | Moderna | No |
| 3 | 2022-05-07 | Moderna | Shingles |
Call center
1 call center case
1 successful
Free text
Release 12 — 3 months, dose 3
Symptoms: Dry cough, sore throat, nasal congestion, shortness of breath, runny nose, fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release